For most healthy people, a fungus called Cryptococcus silently lives in their lungs for their entire lives — walled off by the immune system, doing no harm. Nobody knows it's there. But for people with weakened immune systems — whether from HIV, cancer chemotherapy, organ transplants, or newer drugs for autoimmune conditions — that quiet passenger can awaken, spread to the brain, and prove deadly.
Now, researchers at Virginia Tech in Blacksburg have uncovered a key part of why that reactivation happens. Their discovery, published in the journal mBio, shows that the immune system's sentinels — called CD4 T cells — do not fight the fungus with a single powerful unit, as scientists had assumed. Instead, multiple types of CD4 T cells work together like several chess queens protecting the board, each playing its own crucial role.
"Everybody assumed that we had the queen that was going to be the single most powerful player," said Kirsten Nielsen, a professor of microbiology and immunology at Virginia Tech who led the research. "But it turns out it's not just one queen. Imagine playing chess with five queens."
The findings matter because Cryptococcus kills more than 150,000 people worldwide every year, according to the Centers for Disease Control and Prevention and the World Health Organization. It is the second-leading cause of death among people living with HIV, hitting especially hard in Africa. Right now, doctors have no way to predict which patients will see the fungus reactivate, largely because it was never clear which immune cells were keeping it dormant in the first place.
Nielsen compared CD4 T cells to generals in an army. The front-line soldiers are innate immune cells like macrophages, but the generals — those CD4 T cells — are the ones deciding who fights, where, and when. Disease happens when those generals are lost or fail to send the right orders.
The team collaborated with researchers at Harvard and the University of Illinois, and the work was funded by the National Institutes of Health. This latest discovery is actually the product of nearly two decades of research, going back to a realization Nielsen had while studying how Cryptococcus changes shape inside the body. She noticed those shape changes happened almost entirely in the lungs, which meant the lungs — not the brain, where symptoms eventually appear — were where the outcome of infection was truly decided.
Building mouse models that could reproduce the same quiet, lifelong lung infection seen in humans took years before her lab could even start asking which immune cells mattered. She still has more questions than answers. The team does not yet know exactly what instructions the different T cells send to the front-line soldiers, or which downstream cells each type recruits.
"We don't know what they're telling their troops, or what the troops are hearing, or what troops they're coordinating," Nielsen said. "Those will be the next steps."